Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_assertion type Assertion NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_head.
- NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_assertion description "[Therefore, CPX could be rapidly repurposed for the treatment of malignancies, including leukemia and myeloma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_provenance.
- NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_assertion evidence source_evidence_literature NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_provenance.
- NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_assertion SIO_000772 19589922 NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_provenance.
- NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_assertion wasDerivedFrom befree-20140225 NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_provenance.
- NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_assertion wasGeneratedBy ECO_0000203 NP363645.RAEc5gaxreX1zmSbG0GXn5i162zOdK70Uju4SoJtdl75A130_provenance.